Evidence map›Paper›PMID 25288512›Full record

Trial reportPsychopharmacology2015

Cannabis and creativity: highly potent cannabis impairs divergent thinking in regular cannabis users.

Mikael A Kowal, Arno Hazekamp, Lorenza S Colzato, Henk van Steenbergen, Nic J A van der Wee, Jeffrey Durieux, Meriem Manai, Bernhard Hommel

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Psychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mikael A KowalCognitive Psychology Unit, Institute of Psychology, Leiden University, PO Box 9555, 2300 RB, Leiden, The Netherlands, m.a.kowal@fsw.leidenuniv.nl.
Arno Hazekamp
Lorenza S Colzato
Henk van Steenbergen
Nic J A van der Wee
Jeffrey Durieux
Meriem Manai
Bernhard Hommel
Leiden University · NLLeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleCannabis users often claim that cannabis has the potential to enhance their creativity. Research suggests that aspects of creative performance might be improved when intoxicated with cannabis; however, the evidence is not conclusive.

objectiveThe aim of this study was to investigate the acute effects of cannabis on creativity.

methodsWe examined the effects of administering a low (5.5 mg delta-9-tetrahydrocannabinol [THC]) or high (22 mg THC) dose of vaporized cannabis vs. placebo on creativity tasks tapping into divergent (Alternate Uses Task) and convergent (Remote Associates Task) thinking, in a population of regular cannabis users. The study used a randomized, double-blind, between-groups design.

resultsParticipants in the high-dose group (n = 18) displayed significantly worse performance on the divergent thinking task, compared to individuals in both the low-dose (n = 18) and placebo (n = 18) groups.

conclusionsThe findings suggest that cannabis with low potency does not have any impact on creativity, while highly potent cannabis actually impairs divergent thinking.

Indexed as

CreativityAdolescentCannabinoid Receptor AgonistsDose-Response Relationship, DrugDouble-Blind MethodDronabinolFemaleHumansMaleMarijuana SmokingPsychomotor PerformanceThinkingYoung AdultCannabinoid Receptor AgonistsDronabinol

Identifiers

PMID25288512
PMCPMC4336648
OpenAlexW2118011533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.